Microbiome Therapeutic Strategies (0.75 General + 0.75 Pharmacology CE Credit)

DESCRIPTION

This final session will wrap up the content that has been covered and focus on the future of medicine and microbiome modulation. Microbial modulation therapies, fecal transplant, probiotics, postbiotics, phage and helminths will all be reviewed.

WHAT YOU WILL LEARN

1. Review the development of fecal transplant as a modern medical therapy.
   

2. Assess the role microbial therapeutics including fecal transplant, probiotics, and postbiotics are being developed into pharmaceuticals
   

3. Explain helminthic therapy as a microbial modulation tool that is being explored in clinical trials
   

INSTRUCTOR

Andrea McBeth, ND is an innovative researcher, clinician, and thought leader in the microbiome field. She has vast experience in a variety of lab research settings and previously worked in molecular biology and biomedical engineering at OHSU in Portland, Oregon. Dr. McBeth, along with Dr. Dobner, co-founded Flora Medicine, an integrative clinic based out of Portland, Oregon specializing in functional GI issues and the microbiome. 

A biochemist by training, Dr. McBeth’s technical science background and passion for patient advocacy drives her safety first approach to her work with therapeutics. She is also spending her ‘free time’ as adjunct faculty for the school of graduate studies at NUNM, teaching a basic microbiome class and the influence of nutrition on the microbiome.

CONTINUING EDUCATION APPROVAL

0.75 General + 0.75 Pharmacology CE Credit - American Association of Naturopathic Physicians (AANP)